Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses

被引:11
|
作者
Shi, Zhenguo [1 ,2 ]
Zhu, Xiaojuan [2 ]
Ke, Shaobo [1 ]
Qiu, Hu [1 ]
Cai, Gaoke [1 ]
Zhangcai, Yutian [1 ]
Chen, Yongshun [1 ]
机构
[1] Wuhan Univ, Dept Clin Oncol, Renmin Hosp, Wuhan, Peoples R China
[2] Henan Univ Sci & Technol, Dept Oncol, Affiliated Hosp 1, Luoyang, Peoples R China
基金
中国国家自然科学基金;
关键词
Elderly patients; Synchronous oligometastatic esophageal; squamous cell carcinoma; Concurrent chemoradiotherapy; Survival; Nomogram; CLINICOPATHOLOGICAL CHARACTERISTICS; NEOADJUVANT CHEMORADIOTHERAPY; RADIATION-THERAPY; CANCER; RADIOTHERAPY; ONCOLOGY; CHEMOTHERAPY; MANAGEMENT; OUTCOMES; DISEASE;
D O I
10.1016/j.radonc.2021.09.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the potential benefits of concurrent chemoradiotherapy (CCRT), and to establish a nomogram for predicting survival outcomes of elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma (SOEC). Materials and methods: This study eventually enrolled 314 elderly patients who initially diagnosed with SOEC from two centers. Treatment responses and outcomes of 151 patients receiving CCRT and 163 patients undergoing chemotherapy alone (CT) were compared. Propensity score matching and landmark analyses were performed to control potential confounding factors. A nomogram was established on the basis of the Cox regression model. Results: After a median follow-up of 42.3 months, CCRT was superior to CT alone in objective response rate (ORR, 59.6% vs. 39.9%, P < 0.001), median progression-free survival (PFS, 10.0 vs. 7.2 months, P < 0.001), and median overall survival (OS, 18.5 vs. 15.6 months, P < 0.001). The propensity score matching (PSM) and landmark analyses redemonstrated the same trend (P < 0.01). On hierarchical analysis, patients with 1- 3 metastatic lesions involving one organ displayed longer median PFS (9.0 vs. 7.8 months, P = 0.008) and OS (17.8 vs. 15.2 months, P < 0.001) than those with 4-5 metastatic lesions involving 2-3 organs. The major toxicities of grade III or higher for CCRT included leukocytopenia (23.2%), radiation esophagitis (7.3%), and radiation pneumonitis (8.6%). Cox multivariate analysis showed that the number of metastatic lesions (P = 0.012) and tumor response (P < 0.001) were independent prognostic factors associated with OS. A nomogram was established by incorporating the number of metastatic lesions and tumor response, with a concordance index of 0.743 after internal cross-validation. Calibration curves and decision curve analysis confirmed that nomogram had a favorable predictive value for individualized survival. Conclusions: Compared with CT alone, CCRT exhibited superior efficacy and acceptable toxicity in the first line treatment for elderly patients with SOEC. The current study supports the oligometastatic definition of <3 metastatic lesions involving one organ for esophageal cancer patients. The constructed nomogram can effectively predict the individualized survival. (c) 2021 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 164 (2021) 236-244
引用
收藏
页码:236 / 244
页数:9
相关论文
共 50 条
  • [21] Impact of adjuvant chemotherapy for radically resected esophageal squamous cell carcinoma: a propensity score matching analysis
    Chen, Shao-bin
    Liu, Di-tian
    Chen, Yu-ping
    FRONTIERS IN SURGERY, 2023, 10
  • [22] Survival analysis of 80 elderly patients with esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy with S-1
    Ran, J. -J.
    Shen, J. -J.
    Ma, J.
    Li, X. -Y.
    CANCER RADIOTHERAPIE, 2022, 26 (08): : 1064 - 1069
  • [23] Comparative Analysis of Concurrent Chemoradiotherapy Versus Chemotherapy Alone as First-Line Palliative Treatments for Advanced Esophageal Squamous Cell Carcinoma
    Wonglhow, Jirapat
    Wetwittayakhlang, Panu
    Sunpaweravong, Patrapim
    Sathitruangsak, Chirawadee
    Dechaphunkul, Arunee
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [24] Clinical Impact of the Interval Between Chemoradiotherapy and Esophagectomy in Esophageal Squamous Cell Carcinoma Patients
    Wang, Bing-Yen
    Chen, Hui-Shan
    Hsu, Po-Kuei
    Shih, Chih-Shiun
    Liu, Chao-Yu
    Liu, Chia-Chuan
    Wu, Shiao-Chi
    ANNALS OF THORACIC SURGERY, 2015, 99 (03) : 947 - 955
  • [25] Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma
    Mori, Makiko
    Tsukuda, Mamoru
    Matsuda, Hideki
    Horiuchi, Choichi
    Taguchi, Takahide
    Takahashi, Masahiro
    Nishimura, Goshi
    Komatsu, Masanori
    Niho, Tatsuo
    Sakuma, Naoko
    Miyakoshi, Asako
    Isono, Yasuhiro
    Iwahana, Sayaka
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (04) : 855 - 862
  • [26] The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis
    Manabu Yamamoto
    Mototsugu Shimokawa
    Daisuke Yoshida
    Shohei Yamaguchi
    Mitsuhiko Ohta
    Akinori Egashira
    Masahiko Ikebe
    Masaru Morita
    Yasushi Toh
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 1351 - 1360
  • [27] Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
    Qiu, Xiangnan
    Li, Jing
    Zhou, Han
    Zhang, Meng
    Jiang, Changchen
    Shen, Zetian
    Zhu, XiXu
    Li, Aomei
    Che, Yuxin
    Wu, Tiancong
    Wang, Zhen
    MEDICINE, 2020, 99 (04)
  • [28] Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis
    Chen, Yen-Hao
    Lu, Hung-, I
    Lo, Chien-Ming
    Wang, Yu-Ming
    Chou, Shang-Yu
    Hsiao, Chang-Chun
    Shih, Li-Hsueh
    Chen, Su-Wei
    Li, Shau-Hsuan
    SCIENTIFIC REPORTS, 2018, 8
  • [29] Clinical predictors of survival for elderly patients with esophageal squamous cell carcinoma
    Lai, Kuan-Ming
    Tsai, Chien-Yu
    Yan, Sheng-Lei
    ADVANCES IN DIGESTIVE MEDICINE, 2025, 12 (01)
  • [30] Impact of Chronic Obstruction Pulmonary Disease on Survival in Patients with Advanced Stage Lung Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy
    Chiu, Kuo-Chin
    Lin, Wei-Chun
    Chang, Chia-Lun
    Wu, Szu-Yuan
    CANCERS, 2021, 13 (13)